Last reviewed · How we verify
Preparation Nicotine Mini-Lozenges
At a glance
| Generic name | Preparation Nicotine Mini-Lozenges |
|---|---|
| Sponsor | University of Wisconsin, Madison |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Varenicline for Smoking Reduction in Veterans Not Ready To Quit (PHASE4)
- Cessation Screening Project (PHASE4)
- A Comparative Effectiveness RCT of Optimized Cessation Treatments (PHASE4)
- The Long-Term Quitting (Smoking Cessation) Study (PHASE4)
- Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: